Jump Financial, LLC Cure Vac N.V. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.94 - $4.34 $80,126 - $118,282	27,254 Added 33.14%	109,500 $331,000
Q4 2023 Oct 21, 2024	BUY	$3.96 - $6.41 $241,742 - $391,304	61,046 Added 287.95%	82,246 $346,000
Q4 2023 Feb 07, 2024	BUY	$3.96 - $6.41 $325,694 - $527,196	82,246 New	82,246 $346,000
Q1 2023 Oct 21, 2024	BUY	$6.38 - $12.5 $135,256 - $265,000	21,200 New	21,200 $147,000
Q1 2023 May 03, 2023	BUY	$6.38 - $12.5 $135,256 - $265,000	21,200 New	21,200 $147,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.